1
|
Aminu B, Mukoro GD, Abdullahi S, Makama JG, Modupe OA, Ogbonna UO. Burkitt's Lymphoma of the Breast in an HIV-Positive Patient: A Rare Presentation. J West Afr Coll Surg 2023; 13:116-118. [PMID: 38449543 PMCID: PMC10914096 DOI: 10.4103/jwas.jwas_43_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/12/2023] [Accepted: 03/13/2023] [Indexed: 03/08/2024]
Abstract
Introduction Breast cancer is the most common female cancer worldwide, affecting 13.5-30 per 100,000 women in sub-Saharan Africa. The most common histopathologic variants of breast cancer are those that originate from the glandular epithelium of the breast. Primary breast lymphomas are uncommon, and they represent only 0.04%-0.5% of all breast cancers. Burkitt lymphoma is the least of this rare group. The report intends to present Burkitt's lymphoma, a rare histopathological diagnosis of primary breast tumour in an HIV+ patient. Description of a case of bilateral breast disease and the histopathologic diagnosis. Our case was a 28-year-old HIV+ woman who presented with multiple bilateral breast lumps for 2 months duration, associated with bilateral axillary lumps, weight loss, night sweat, and malaise. Lumps range from 2 to 8 cm in size with multiple axillary lymph nodes. Core tissue biopsy showed a monotonous population of intermediate-sized lymphoid cells with round nuclei, clumped chromatin, and several nucleoli interspersed by numerous tangible body macrophages, presenting a starry-sky appearance. Diagnosis of bilateral primary breast Burkitt's lymphoma was performed, and the patient was referred to oncology. She was placed on antiretroviral therapy and chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristine sulphate, and prednisone) and clinically responded to therapy. Conclusions Breast lumpiness in immunocompromised patients calls for the suspicion of lymphoma.
Collapse
Affiliation(s)
- Bashir Aminu
- Department of Surgery, Barau Dikko Teaching Hospital, Kaduna, Nigeria
| | - George Duke Mukoro
- Department of Surgery, Ahmadu-Bello University Teaching Hospital, Zaria, Nigeria
| | - Shehu Abdullahi
- Department of Histopathology, Ahmadu Bello University, Zaria, Nigeria
| | | | - Ogunsina A Modupe
- Department of Internal Medicine, Barau Dikko Teaching Hospital, Kaduna, Kaduna State, Nigeria
| | | |
Collapse
|
2
|
Fomete B, Samaila MOA, Omeje KU, Agbara R, Abdullahi S, Adebayo ET, Ikhekuamen EA. Giant Ameloblastoma and the Risk of Recurrence: Experiences from a Tertiary Hospital. West Afr J Med 2022; 39:350-354. [PMID: 35488879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
BACKGROUND Ameloblastoma is an aggressive tumor of odontogenic epithelium that grows slowly with propensity for bone expansion. Sometimes it may grow to very large sizes also known as giant ameloblastoma (GA) which may affect function and even pose a threat to life. OBJECTIVE To present the pattern of presentation of GAs seen in a tertiary centre in Northern Nigeria. PATIENTS AND METHODS A retrospective study of patients seen with GA at the Oral and Maxillofacial Clinic of a tertiary health facility of Northern Nigeria between January 2006 to December 2019. All patients with complete documentation in the folder, theatre register and histopathologic records were recruited for the study. Data were analyzed using SPSS version 23. RESULTS GAs accounted for 30.2% (48) of all the ameloblastomas operated during the period with a male dominance of 62.5% (30), giving a ratio of 1.7:1(M:F). The age range was between 12 and 65 years with a mean age of 35.04years (±14.5) and the mandible was the most affected jaw compared to the maxilla (12.5%). Lesions with lowest and highest weight were found on the mandible (77g and 1640g respectively). The treatment most given was mandibulectomy (unspecified) with 20.0% followed by Rt and Lt mandibulectomies with 14.0% each. CONCLUSION GA was found to account for 30.2% of all lesions seen within the period under review, while the mandible was the most affected jaw bone.
Collapse
Affiliation(s)
- B Fomete
- Maxillofacial Surgery Department, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
| | - M O A Samaila
- Pathology Department, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
| | - K U Omeje
- Oral and Maxillofacial Surgery Department, Aminu Kano Teaching Hospital, Kano, Kano State, Nigeria
| | - R Agbara
- Oral and Maxillofacial Surgery Department, Jos University Teaching Hospital, Jos, Plateau State, Nigeria
| | - S Abdullahi
- Pathology Department, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
| | - E T Adebayo
- Oral and Maxillofacial Surgery Department, Faculty of Dentistry, University of Medical Sciences, Ondo, Ondo State, Nigeria
| | - E A Ikhekuamen
- Maxillofacial Surgery Department, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria
| |
Collapse
|
3
|
Liman AA, Kabir B, Abubakar M, Abdullahi S, Ahmed SA, Shehu SM. Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria. Niger J Clin Pract 2022; 25:97-104. [PMID: 35046202 DOI: 10.4103/njcp.njcp_437_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background Breast cancer (BC) is a common malignancy; the most frequent in Nigeria. BC characteristically exhibits great biologic diversity. Amongst its variants, the triple-negative subtype is also characterized by heterogeneity (thus making it a study in diversity within diversity) and also by some unique clinicopathologic features including clinical aggressiveness, lack of response to current targeted therapies, and tendency to cluster amongst young premenopausal women especially in populations of women of African ancestry. Aims The objective of this study was to conduct a retrospective clinicopathologic survey of all breast carcinomas to profile the triple-negative breast cancers (TNBCs) amongst them and illustrate their immunohistochemical pattern of luminal androgen receptors (LARs) expression. Patients and Methods All the cases entered into the departmental records as breast carcinomas over the study period were extracted including patients' request cards, hematoxylin and eosin-stained slides, and paraffin-embedded tissue blocks of those diagnosed as triple-negative cancers. These were immunohistochemically stained using a monoclonal antibody for androgen receptor (AR). The whole data were analyzed and presented in tabular formats. Results A total of 660 breast carcinomas of which 89 (13.48%) cases were identified as TNBCs with a mean age of occurrence of 42.89 ± 11.88 years. Most TNBCs (95.5%) were carcinoma no special type and 61.8% had low or intermediate histologic grading. LAR expression was noted in 11.24% of the TNBCs. Conclusion Triple-negative cancer in this study shares some of the known characteristics but also portrays some divergence from the commonly described features.
Collapse
Affiliation(s)
- A A Liman
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - B Kabir
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - M Abubakar
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - S Abdullahi
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - S A Ahmed
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - S M Shehu
- Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| |
Collapse
|
4
|
Ghafuri DL, Greene BC, Musa B, Gambo A, Sani A, Abdullahi S, Widil BJ, Bello-Manga H, Gambo S, Ghafuri M, Cassell H, Neville K, Kirkham F, Kassim AA, Aliyu MH, DeBaun MR, Jordan LC. Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa. Pediatr Neurol 2021; 125:9-15. [PMID: 34563875 PMCID: PMC8559257 DOI: 10.1016/j.pediatrneurol.2021.08.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 08/27/2021] [Accepted: 08/28/2021] [Indexed: 11/27/2022]
Abstract
BACKGROUND Nigeria has the highest proportion of children with sickle cell anemia (SCA) globally; an estimated 150,000 infants with SCA are born annually. Primary stroke prevention in children with SCA must include Nigeria. We describe capacity-building strategies in conjunction with two National Institutes of Health-funded primary stroke prevention trials (a feasibility trial and phase III randomized controlled trial) with initial hydroxyurea treatment for children with SCA and abnormal transcranial Doppler (TCD) velocities in Nigeria. We anticipated challenges to conducting clinical trials in a low-resource setting with a local team that had not previously been involved in clinical research and sought a sustainable strategy for primary stroke prevention. METHODS This is a descriptive, prospective study of challenges, solutions, and research teams in two trials that enrolled a total of 679 children with SCA. RESULTS As part of the capacity-building component of the trials, over eight years, 23 research personnel (physicians, nurses, research coordinators, a statistician, and a pharmacist) completed a one-month research governance and ethics training program at Vanderbilt University Medical Center, USA. A lead research coordinator for each site completed the Society of Clinical Research Professionals certification. TCD machines were donated; radiologists and nonradiologists were trained and certified to perform TCD. A scalable E-prescription was implemented to track hydroxyurea treatment. We worked with regional government officials to support ongoing TCD-based screening and funding for hydroxyurea for children with SCA at a high risk of stroke. CONCLUSIONS Our trials and capacity building demonstrate a sustainable strategy to initiate and maintain pediatric SCA primary stroke prevention programs in Africa.
Collapse
Affiliation(s)
- Djamila L. Ghafuri
- Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Tennessee, U.S.A
| | - Brittany Covert Greene
- Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Tennessee, U.S.A
| | - Bilya Musa
- Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria
| | - Awwal Gambo
- Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria
| | - Abdulrasheed Sani
- Department of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria
| | - Shehu Abdullahi
- Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria
| | - Binta J. Widil
- Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria
| | - Halima Bello-Manga
- Department of Hematology and Blood Transfusion, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria
| | - Safiya Gambo
- Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria
| | - Matin Ghafuri
- Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Tennessee, U.S.A
| | - Holly Cassell
- Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, U.S.A
| | - Kathleen Neville
- Department of Pediatrics, Divisions of Pediatric Hematology-Oncology and Clinical Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas
| | - Fenella Kirkham
- Department of Pediatrics, University of Arkansas for Medical Sciences/Arkansas Children’s Hospital, Little Rock, AR, U.S.A
| | - Adetola A. Kassim
- Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, U.S.A
| | - Muktar H. Aliyu
- Health Policy, Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Tennessee, U.S.A
| | - Michael R. DeBaun
- Vanderbilt-Meharry Sickle Cell Center for Excellence, Department of Pediatrics, Vanderbilt University School of Medicine, Tennessee, U.S.A
| | - Lori C. Jordan
- Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University of Medicine, Tennessee, U.S.A
| |
Collapse
|
5
|
Bello-Manga H, Galadanci AA, Abdullahi S, Ali S, Jibir B, Gambo S, Haliru L, Jordan LC, Aliyu MH, Rodeghier M, Kassim AA, DeBaun MR, Galadanci NA. Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial. Br J Haematol 2020; 190:939-944. [PMID: 32415792 DOI: 10.1111/bjh.16746] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Revised: 04/21/2020] [Accepted: 04/22/2020] [Indexed: 02/06/2023]
Abstract
Severe anaemia, defined as haemoglobin level < 6·0 g/dl, is an independent risk factor for death in individuals with sickle cell disease living in resource-limited settings. We conducted a cross-sectional study of 941 children with sickle cell anaemia, who had been defined as phenotype HbSS or HbSβ0 thalassaemia, aged five to 12 years, and were screened for enrollment into a large primary stroke prevention trial in Nigeria (SPRING; NCT02560935). The main aim of the study was to determine the prevalence and risk factors for severe anaemia. We found severe anaemia to be present in 3·9% (37 of 941) of the SPRING study participants. Severe anaemia was significantly associated with the lower educational level of the head of the household (P = 0·003), as a proxy for poverty, and a greater number of children per room in the household (P = 0·004). Body mass index was not associated with severe anaemia. The etiology of severe anaemia in children living with sickle cell anaemia in Nigeria is likely to be multifactorial with an interplay between an individual's disease severity and other socio-economic factors related to poverty.
Collapse
Affiliation(s)
- Halima Bello-Manga
- Department of Hematology and Blood Transfusion, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria
| | - Aisha A Galadanci
- Department of Hematology and Blood Transfusion, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria
| | - Shehu Abdullahi
- Department of Pediatrics, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria
| | - Shehi Ali
- Department of Radiology, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria
| | - Binta Jibir
- Department of Pediatrics, Hasiya Bayero Children's Hospital, Kano, Nigeria
| | - Safiya Gambo
- Department of Pediatrics, Murtala Muhammad Specialist Hospital Kano, Kano, Nigeria
| | - Lawal Haliru
- Department of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria
| | - Lori C Jordan
- Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University of Medicine, Nashville, TN, USA
| | - Muktar H Aliyu
- Family Medicine/Preventive Medicine, Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA
| | | | - Adetola A Kassim
- Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Michael R DeBaun
- Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Najibah A Galadanci
- Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
6
|
Samaila MO, Aliyu HO, Yusufu LM, Abdullahi S. Concurrent giant tumoral pseudoangiomatous stromal hyperplasia necessitating bilateral mastectomy. Ann Afr Med 2018; 17:82-85. [PMID: 29536962 PMCID: PMC5875124 DOI: 10.4103/aam.aam_27_17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign mesenchymal tumor of the breast. Majority occur as diffuse lesions, and diagnosis is often incidental or in a background of other breast pathologies. Bilaterality with multiple tumoral masses in giant breasts is a rarity. We report a 34-year-old nonlactating female with 2-year history of rapid progressive painless bilateral enlargement of the breasts following surgical excision of ill-defined breast lumps which were not subjected to histopathological evaluation a year earlier. Examination revealed bilateral nontender giant breasts extending to the umbilical area with masses which were not attached to overlying skin, Grade 2 pressure ulcers on the lateral posterior breast aspects bilaterally and peau d'orange. There were no other palpable masses or lymph nodes. A clinical assessment of bilateral gigantomastia was made. Bilateral mastectomy revealed giant PASH which was confirmed with positive immunohistochemical reactivity for CD34 and vimentin. No other breast pathologies were seen with extensive sectioning. Diffuse multiple breast lesions with incomplete excision are associated with rapid growth in PASH as seen in this case. The presence of concurrent bilateral giant tumoral masses without any underlying breast pathology is a novelty. The mainstay of treatment in this case is mastectomy despite its benign nature.
Collapse
Affiliation(s)
- Modupeola Omotara Samaila
- Department of Pathology, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital Zaria, Nigeria
| | - Halima Oziohu Aliyu
- Department of Pathology, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital Zaria, Nigeria
| | - Lazarus Mungu Yusufu
- Department of Surgery, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital Zaria, Nigeria
| | - Shehu Abdullahi
- Department of Pathology, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital Zaria, Nigeria
| |
Collapse
|
7
|
Diaku-Akinwumi IN, Abubakar SB, Adegoke SA, Adeleke S, Adewoye O, Adeyemo T, Akinbami A, Akinola NO, Akinsulie A, Akinyoola A, Aneke J, Awwalu S, Babadoko A, Brown B, Ejike O, Emodi I, George I, Girei A, Hassan A, Kangiwa GU, Lawal OA, Mabogunje C, Madu AJ, Mustapha A, Ndakotsu M, Nnodu OE, Nwaneri D, Odey F F, Ohiaeri C, Olaosebikan R, Olatunya O OS, Oniyangi O, Opara H, Ugwu NI, Musa AU, Abdullahi S, Usman A, Utuk E, Jibir BW, Adekile AD. Blood transfusion services for patients with sickle cell disease in Nigeria. Int Health 2016; 8:330-5. [DOI: 10.1093/inthealth/ihw014] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2015] [Accepted: 01/04/2016] [Indexed: 01/07/2023] Open
|
8
|
Makusidi MA, Liman HM, Yakubu A, Isah MD, Abdullahi S, Chijioke A. Hemodialysis performance and outcomes among end stage renal disease patients from Sokoto, North-Western Nigeria. Indian J Nephrol 2014; 24:82-5. [PMID: 24701039 PMCID: PMC3968614 DOI: 10.4103/0971-4065.127889] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The cost of managing end stage renal disease (ESRD) is prohibitive in Nigeria and the burden is solely borne by patients and their relatives. Despite increasing number of dialysis centers in urban areas, actual utilization of such facilities is very low. It is unclear if the outcomes of these patients have improved in recent times. We evaluated pattern of hemodialysis (HD) performance and outcome among ESRD patients. A 5-year prospective cross-sectional study of all ESRD patients on HD was undertaken. The final outcomes included duration on maintenance dialysis, death from inability to sustain dialysis, absconded, confirmed deaths within or outside health facility or referral for kidney transplant. A total of 540 (54%) of 976 cases of ESRD commenced HD, out of which 7 (1.3%) eventually had live-related kidney transplant in India. The male to female ratio was 2:1 with male and female mean ages of 43 ± 17 and 36 ± 16 years respectively. There was a progressive annual increase in the number of ESRD patients. The commonest underlying renal disorder was chronic glomerulonephritis. The mean HD session duration was 8.11 ± 5.4 hours, while the mean duration of stay on HD was 8.72 ± 1.0 weeks. In conclusion, ESRD is common and is being increasingly recognized. Financial constraint and late presentation are major contributory factors to poor outcomes despite the widespread availability of HD facilities. Therefore, effort should be geared towards aggressive strategies for early detection and treatment. Government commitment in terms of funding and/or subsidy for patient with ESRD is advocated.
Collapse
Affiliation(s)
- M A Makusidi
- Department of Medicine, Usmanu Danfodiyo, University Teaching Hospital, Sokoto, Nigeria
| | - H M Liman
- Department of Medicine, Usmanu Danfodiyo, University Teaching Hospital, Sokoto, Nigeria
| | - A Yakubu
- Department of Medicine, Usmanu Danfodiyo, University Teaching Hospital, Sokoto, Nigeria
| | - M D Isah
- Department of Medicine, Usmanu Danfodiyo, University Teaching Hospital, Sokoto, Nigeria
| | - S Abdullahi
- Department of Nursing, Usmanu Danfodiyo, University Teaching Hospital, Sokoto, Nigeria
| | - A Chijioke
- Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria
| |
Collapse
|
9
|
Mansurah AA, Aimola I, Annette RO, Abdullahi S. Isolation, Partial Purification and Characterization of Angiotensin Converting
Enzyme (ACE) from Rabbit (Oryctolagus ciniculus) Lungs. ACTA ACUST UNITED AC 2013. [DOI: 10.3923/ajdd.2013.120.129] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
10
|
Mohammed A, Abdullahi K, Mohammed U, Aliyu HO, Liman AA, Abdullahi S, Bello HM, Abubakar N, Abubakar M, Akpobi KC, Mafara UB. Disseminated Langerhan's cell histiocytosis: a case report and review of the literature. Ann Afr Med 2011; 10:310-3. [PMID: 22064259 DOI: 10.4103/1596-3519.87050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Langerhan's cell histiocytosis is characterized by the presence of large mononucleated cells associated with inflammatory cells. We describe the clinical presentation, histopathology and some immunohistochemistry findings, in an eight-year-old female patient.
Collapse
Affiliation(s)
- Abdullahi Mohammed
- Department of Pathology, Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Ehimiyein A, Niezgoda M, Orciari L, Kuzmin I, Osinubi M, Ehimiyein I, Adawa D, Abdullahi S, Ogunkoya A, Rupprecht C. Rabies cases in dog markets in Kaduna state, northern Nigeria. Int J Infect Dis 2010. [DOI: 10.1016/j.ijid.2010.02.675] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
12
|
Mohammed I, Nasidi A, Alkali AS, Garbati MA, Ajayi-Obe EK, Audu KA, Usman A, Abdullahi S. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans R Soc Trop Med Hyg 2000; 94:265-70. [PMID: 10974995 DOI: 10.1016/s0035-9203(00)90316-x] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A particularly severe epidemic of meningococcal meningitis (cerebrospinal meningitis, CSM) occurred in Nigeria between January and June 1996. There were 109,580 recorded cases and 11,717 deaths, giving a case fatality rate of 10.7% overall. This is the most serious epidemic of CSM ever recorded in Nigeria, and may be the largest in Africa this century. It took over 3 months and the combined efforts of a National Task Force set up by the Federal Ministry of Health, the WHO, UNICEF, UNDP, Médecins Sans Frontières, the International Red Cross and several other non-governmental organizations to bring the epidemic under control. The main control measures centred on active treatment of infected persons, mass vaccination and health education. The exact number of persons treated cannot be ascertained, but there were treatment centres in almost every Local Government Area in the affected States. A study of 1577 patients admitted at the Infectious Diseases Hospital, Kano, showed that 84% of those infected were aged < or = 20 years and that, for the first time, infants aged < or = 2 months were affected. Despite intervention, the case fatality rate of 9.1% among this group of patients was similar to the nationwide figure of 10.7%. Long-acting oily chloramphenicol proved highly effective in the treatment of patients, and its routine use in epidemic CSM is recommended. Over 13 million persons were vaccinated in the course of the epidemic. For the first time, cases of CSM were reported from States south of the 'African meningitis belt', suggesting an extension of the belt. The severity of this epidemic yet again underscores the need for a clear policy regarding control measures aimed at forestalling future epidemics. The availability of the recently developed polysaccharide-protein conjugate vaccine should facilitate a decision on mass vaccination for the prevention of epidemic CSM in Africa.
Collapse
Affiliation(s)
- I Mohammed
- Department of Medicine, University of Maiduguri, Nigeria.
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Osborne CA, Abdullahi S, Klausner JS, Johnston GR, Polzin DJ. Nonsurgical removal of uroliths from the urethra of female dogs. J Am Vet Med Assoc 1983; 182:47-50. [PMID: 6822460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|